Search
for
Sort by
Research 61–90 of 1000+
- 62202 Network meta-analysis (NMA) of FDA-approved JAK inhibitors for alopecia areata (AA) with at least 50% hair loss per SALT score
- Alopecia areata incognito: A rare cause of hair loss in children
- Female pattern hair loss possibly caused by tamoxifen: Androgen receptor expression in the outer root sheath in the affected area
- 52709 Patient-Reported Outcomes for Scalp, Eyebrow and Eyelash Hair Loss in Patients with Severe Alopecia Areata Treated with Baricitinib: 152 Week Results from two Phase 3 Clinical Trials
- 0047 Loss of transposable element silencing sensitizes hair follicles to immune privilege collapse in alopecia areata
- Stem cell secretome as a mechanism for restoring hair loss due to stress, particularly alopecia areata: narrative review
- Improvement in Patient‐Reported Emotional Symptoms and Activity Limitations due to Hair Loss in Patients With Alopecia Areata Treated With Ritlecitinib: Additional Analyses From ALLEGRO ‐2b/3
- FDA approves Pfizer's JAK inhibitor for adolescents with alopecia areata hair loss
- Diffuse alopecia areata is associated with intense inflammatory infiltration and CD8+ T cells in hair loss regions and an increase in serum IgE level
- Autoantibodies to Hair Follicles in C3H/HeJ Mice With Alopecia Areata–Like Hair Loss
- Long‐term safety and efficacy of ritlecitinib in adults and adolescents with alopecia areata and at least 25% scalp hair loss: Results from the ALLEGRO‐LT phase 3, open‐label study
- 33774 Baricitinib results in eyebrow and eyelash growth in patients with alopecia areata who do not achieve 20% or less scalp hair loss
- Quantitative evaluation of carcinosin as an individualized remedy in pediatric alopecia areata using salt score and ludwig hair loss scales: A case report
- Reddit Analysis Reveals Common Questions of Patients with Alopecia Areata about JAK Inhibitors for Hair Loss.
- Study of the Prevalence of Different Causes of Hair Loss among Females with Polycystic Ovary Syndrome in Delta Area-Egypt
- 72676 Dysregulated circulating protein biomarkers are correlative with hair loss and predictive of hair growth in alopecia areata
- 75478 Symptoms, Emotional and Functional Impacts by Hair Loss Severity in Alopecia Areata
- Correction to ‘Long‐term safety and efficacy of ritlecitinib in adults and adolescents with alopecia areata and at least 25% scalp hair loss: Results from the ALLEGRO‐LT phase 3, open‐label study’
- Using platelet-rich plasma to treat hair loss and thinning
- Diffuse hair loss
- Diagnosing and treating hair loss.
- Trichoscopic Findings of Hair Loss in Koreans
- Enhancing alopecia areata management: Nanocrystal-driven strategy for targeting hair follicles
- Sudden onset hair loss and colour change
- A clincodermoscopic evaluation of chronic diffuse hair loss among females in a Tertiary Care Center
- A patient with diffuse hair loss
- “‘You lose your hair, what’s the big deal?’ I was so embarrassed, I was so self-conscious, I was so depressed:” a qualitative interview study to understand the psychosocial burden of alopecia areata
- Hair loss in infancy and childhood
- Hair Loss Effects and Surgical/Drug Treatments for the Alopecias
- Isotretinoin and Hair Loss: A Clinical Perspective and Literature Review